Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Approvable letter received for Ariflo

Oct. 30, 2003

Novartis describes new CCR3 antagonists with utility in asthma therapy

Oct. 30, 2003

Indian group identifies new antiallergic/antiasthmatic agents

Oct. 30, 2003

Novel elastase inhibitors prepared and tested by Dainippon scientists

Oct. 28, 2003

Quinoline-based PDE4 inhibitors and their use covered by Merck Frosst patent

Oct. 27, 2003

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003

Baxter completes acquisition of Aralast

Oct. 24, 2003

AVP-13358 well tolerated in phase I trial

Oct. 24, 2003

New muscarinic M3 antagonists covered by Boehringer Ingelheim patent

Oct. 24, 2003

AstraZeneca describes a novel series of dual CCR3 modulators/H1 antagonists

Oct. 24, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...